Filing Details
- Accession Number:
- 0000904454-23-000061
- Form Type:
- 13G Filing
- Publication Date:
- 2023-01-26 19:00:00
- Filed By:
- Johnson & Johnson
- Company:
- Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
- Filing Date:
- 2023-01-27
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| (VOLUNTARY) Johnson Johnson | 0 | 3,670,516 | 0 | 3,670,516 | 3,670,516 | 8.2% |
| (VOLUNTARY) Johnson Johnson Innovation-JJDC, Inc | 0 | 3,670,516 | 0 | 3,670,516 | 3,670,516 | 8.2% |
Filing
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| SCHEDULE 13G |
| (Rule 13d-102) |
| INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT |
| TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED |
| PURSUANT TO RULE 13d-2(b) |
| (Amendment No. 1 )1 |
| Fusion Pharmaceuticals Inc. |
| (Name of Issuer) |
| Common Shares, no par value |
| (Title of Class of Securities) |
| 36118A100 |
| (CUSIP Number) |
| December 31, 2022 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
1 The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act.
CUSIP No. 36118A100
| 1. | NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (VOLUNTARY) Johnson & Johnson | |||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) [ ] (b) [ ] | ||
| 3. | SEC USE ONLY | |||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey | |||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER | -0- | |
| 6. | SHARED VOTING POWER | 3,670,516 | ||
| 7. | SOLE DISPOSITIVE POWER | -0- | ||
| 8. | SHARED DISPOSITIVE POWER | 3,670,516 | ||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 3,670,516 | ||
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | [ ] | ||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | 8.2% | ||
| 12. | TYPE OF REPORTING PERSON | CO | ||
2
CUSIP No. 36118A100
| 1. | NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (VOLUNTARY) Johnson & Johnson Innovation-JJDC, Inc. | ||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) [ ] (b) [ ] | |||
| 3. | SEC USE ONLY | ||||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER | -0- | ||
| 6. | SHARED VOTING POWER | 3,670,516 | |||
| 7. | SOLE DISPOSITIVE POWER | -0- | |||
| 8. | SHARED DISPOSITIVE POWER | 3,670,516 | |||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 3,670,516 | |||
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | [ ] | |||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | 8.2% | |||
| 12. | TYPE OF REPORTING PERSON | CO | |||
3
CUSIP No. 36118A100
AMENDMENT NO. 1 TO SCHEDULE 13G
Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons with respect to the Common
Shares of the Issuer on July 2, 2020 (the “Schedule 13G”). Terms defined in the Schedule 13G are used herein as so defined.
The following item of the Schedule 13G is amended and restated to read in its entirety as follows:
Item 4. Ownership
(a) through (c):
The information requested in these paragraphs is incorporated by reference to the cover pages to this Amendment No. 1 to Schedule 13G. Percentage ownership is
based on 44,762,514 Common Shares outstanding as of October 28, 2022, as reported in the Issuer’s Report on Form 10-Q for the period ended September 30, 2022 filed with the Securities and Exchange Commission on November 8, 2022.
4
CUSIP No. 36118A100
SIGNATURE
After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true,
complete and correct.
Dated: January 27, 2023
| JOHNSON & JOHNSON | ||
| By: | /s/ Marc Larkins | |
| Name: | Marc Larkins | |
| Title: | Secretary | |
| JOHNSON & JOHNSON INNOVATION-JJDC, INC. | ||
| By: | /s/ Jill McManus | |
| Name: | Jill McManus | |
| Title: | Assistant Treasurer | |
5